Published in Eur Respir J on February 08, 2013
Endobronchial Mucosal Biopsy in Patients With Suspected Pulmonary Sarcoidosis | NCT04904939
Nonsteroidal therapy of sarcoidosis. Curr Opin Pulm Med (2013) 1.08
Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep (2014) 0.96
Adalimumab Induced Subcutaneous Nodular Sarcoidosis; A Rare Side Effect of Tumor Necrosis Factor-α Inhibitor. Sarcoidosis Vasc Diffuse Lung Dis (2014) 0.84
Efficacy of mycophenolate mofetil in sarcoidosis. Respir Med (2014) 0.80
The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis. Respir Med (2015) 0.77
Refractory pulmonary sarcoidosis - proposal of a definition and recommendations for the diagnostic and therapeutic approach. Clin Pulm Med (2016) 0.76
Dry cough in a middle-aged man. Lung India (2016) 0.75
New molecular targets for the treatment of sarcoidosis. Curr Opin Pulm Med (2016) 0.75
Pulmonary tuberculosis followed by sarcoidosis in an HIV-infected patient: A case report and a simplified diagnostic flowchart for diagnosis and treatment of sarcoidosis. Respir Med Case Rep (2016) 0.75
Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel. Respir Med Case Rep (2015) 0.75
Reliability of Cardiovascular Risk Calculators to Estimate Accurately the Risk of Cardiovascular Disease in Patients With Sarcoidosis. Am J Cardiol (2017) 0.75
Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain. Medicine (Baltimore) (2017) 0.75
Use of PET-CT for the assessment of treatment results in patients with sarcoidosis. Wien Klin Wochenschr (2014) 0.75
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol (2002) 4.79
Sarcoidosis. Lancet (2003) 3.60
Acute respiratory failure after interferon-gamma therapy of end-stage pulmonary fibrosis. Am J Respir Crit Care Med (2003) 2.84
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis (2010) 2.30
Therapy for sarcoidosis: evidence-based recommendations. Expert Rev Clin Immunol (2012) 2.28
Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest (2010) 2.25
Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis. Eur Respir J (2012) 2.11
Racial difference in sarcoidosis mortality in the United States. Chest (2015) 1.93
Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature. Medicine (Baltimore) (2014) 1.65
FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review. Autoimmun Rev (2013) 1.62
Sarcoidosis-associated fatigue. Eur Respir J (2012) 1.57
Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease. Thorax (2010) 1.55
18F-fluorodeoxyglucose positron emission tomography/computer tomography as an objective tool for assessing disease activity in Sjögren's syndrome. Autoimmun Rev (2013) 1.52
Who dies from sarcoidosis and why? Am J Respir Crit Care Med (2011) 1.42
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study. Arthritis Rheum (2008) 1.41
Features of sarcoidosis associated with chronic disease. Sarcoidosis Vasc Diffuse Lung Dis (2015) 1.41
Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med (2002) 1.34
Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Chest (2005) 1.29
Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors. Respiration (2011) 1.27
Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest (2007) 1.27
Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev (2012) 1.22
The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population. PLoS One (2013) 1.21
Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum (2011) 1.20
Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience. J Clin Rheumatol (2009) 1.17
Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol (2012) 1.15
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis (2014) 1.12
Nonsteroidal therapy of sarcoidosis. Curr Opin Pulm Med (2013) 1.08
Sarcoidosis, fatigue, and sleep apnea. Chest (2013) 1.08
Ocular sarcoidosis. Semin Respir Crit Care Med (2010) 1.07
Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis. PLoS One (2012) 1.05
Six-minute walk test and health status assessment in sarcoidosis. Chest (2007) 1.05
Laryngeal sarcoidosis: a case-control study. Sarcoidosis Vasc Diffuse Lung Dis (2014) 1.02
CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells. Appl Immunohistochem Mol Morphol (2002) 1.01
Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study. Eur J Heart Fail (2011) 1.00
Rituximab in the treatment of refractory pulmonary sarcoidosis. Eur Respir J (2014) 0.98
Therapy for extrapulmonary sarcoidosis. Semin Respir Crit Care Med (2002) 0.98
Pulmonary hypertension in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2006) 0.96
Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival. Eur Respir J (2013) 0.95
Bone fragility in sarcoidosis and relationships with calcium metabolism disorders: a cross sectional study on 142 patients. Arthritis Res Ther (2014) 0.95
Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab. Am J Kidney Dis (2010) 0.95
Treatment of Sarcoidosis. Clin Rev Allergy Immunol (2015) 0.93
Pulmonary cavitary sarcoidosis: clinico-radiologic characteristics and natural history of a rare form of sarcoidosis. Medicine (Baltimore) (2008) 0.93
Interstitial lung disease and gastroesophageal reflux disease: key role of esophageal function tests in the diagnosis and treatment. Arq Gastroenterol (2011) 0.93
Small airways diseases, excluding asthma and COPD: an overview. Eur Respir Rev (2013) 0.93
Upper airway. 4: Sarcoidosis of the upper respiratory tract (SURT). Thorax (2010) 0.93
Bone health issues in sarcoidosis. Curr Rheumatol Rep (2011) 0.92
Leflunomide for chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2004) 0.90
The minor salivary gland biopsy as a diagnostic tool for Sjogren syndrome. Laryngoscope (2009) 0.89
Sinonasal involvement in sarcoidosis: a case-control study of 20 patients. Medicine (Baltimore) (2006) 0.89
Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study. J Clin Oncol (2004) 0.88
Thalidomide for chronic sarcoidosis. Chest (2002) 0.88
Endoluminal stenosis of proximal bronchi in sarcoidosis: bronchoscopy, function, and evolution. Chest (2005) 0.87
Imbalance of circulating endothelial cells and progenitors in idiopathic pulmonary fibrosis. Angiogenesis (2012) 0.87
Ocrelizumab: a step forward in the evolution of B-cell therapy. Expert Opin Biol Ther (2009) 0.86
Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis. Ther Clin Risk Manag (2010) 0.86
Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange. Chest (2004) 0.86
Prognostic relevance of histological variants in nonspecific interstitial pneumonia. Histopathology (2014) 0.85
CT findings in severe thoracic sarcoidosis. Eur Radiol (2004) 0.84
Adalimumab Induced Subcutaneous Nodular Sarcoidosis; A Rare Side Effect of Tumor Necrosis Factor-α Inhibitor. Sarcoidosis Vasc Diffuse Lung Dis (2014) 0.84
Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2002) 0.84
Imaging of Sarcoidosis. Clin Rev Allergy Immunol (2015) 0.84
Newer therapies for cutaneous sarcoidosis: the role of thalidomide and other agents. Am J Clin Dermatol (2004) 0.84
Efficacy and safety of apremilast in chronic cutaneous sarcoidosis. Arch Dermatol (2011) 0.83
Novel therapies for sarcoidosis. Semin Respir Crit Care Med (2007) 0.83
Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems. Am J Clin Dermatol (2008) 0.83
High-resolution computed tomography to differentiate chronic diffuse interstitial lung diseases with predominant ground-glass pattern using logical analysis of data. Eur Radiol (2009) 0.82
Nephrogenic systemic fibrosis associated with stromal and vascular calcification, report of two cases. J Cutan Pathol (2008) 0.81
Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial. Sarcoidosis Vasc Diffuse Lung Dis (2016) 0.81
Bilateral synchronous breast cancer and HER-2/neu overexpression. Breast Cancer Res Treat (2002) 0.81
Tumor necrosis factor inhibition in the treatment of refractory sarcoidosis: slaying the dragon? J Rheumatol (2007) 0.81
Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. J Nucl Cardiol (2012) 0.80
Diagnosis and management of spinal cord sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2006) 0.80
Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr Opin Pulm Med (2013) 0.80
Utility of lip biopsy in the diagnosis and treatment of Sjogren's syndrome. Laryngoscope (2007) 0.80
Quality of life in sarcoidosis: assessment and management. Semin Respir Crit Care Med (2010) 0.79
Evidence-based therapy for cutaneous sarcoidosis. Clin Dermatol (2007) 0.79
Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease. Cytokine (2013) 0.79
Advanced pulmonary sarcoidosis. Curr Opin Pulm Med (2014) 0.78
Six-minute walk test in managing and monitoring sarcoidosis patients. Curr Opin Pulm Med (2007) 0.78
Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma. J Clin Rheumatol (2010) 0.78
Fatigue in sarcoidosis: a systematic review. Curr Opin Pulm Med (2009) 0.78
[Epidemiology of interstitial lung diseases]. Presse Med (2009) 0.77
High-resolution computed tomographic imaging of airways in sarcoidosis patients with airflow obstruction. J Comput Assist Tomogr (2009) 0.77
Purtscher-like retinopathy in a patient with adult-onset Still's disease and concurrent thrombotic thrombocytopenic purpura. Arthritis Rheum (2007) 0.77
[Combined pulmonary fibrosis and emphysema]. Presse Med (2007) 0.77
[Pulmonary hypertension associated with systemic sclerosis]. Ann Med Interne (Paris) (2002) 0.77
Nuclear magnetic resonance spectroscopic analysis of salivary metabolome in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2016) 0.76
Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice. J Womens Health Gend Based Med (2002) 0.76
Goldilocks, vitamin D and sarcoidosis. Arthritis Res Ther (2014) 0.76
Clinical and radiological features of Takayasu's arteritis patients in Jordan. Rheumatol Int (2009) 0.76
Full-thickness eyelid lesions in sarcoidosis. Case Rep Ophthalmol Med (2013) 0.76
Clonality and phenotyping analysis of alveolar lymphocytes is suggestive of pulmonary MALT lymphoma. Respir Med (2011) 0.76
Pulmonary manifestations of sarcoidosis. Presse Med (2012) 0.76
Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients. Respir Med (2013) 0.75
Can persistent tumor necrosis factor release lead to refractory sarcoidosis? Sarcoidosis Vasc Diffuse Lung Dis (2002) 0.75
Sarcoid Pericarditis and Large Vessel Vasculitis Detected on FDG PET/CT. Clin Nucl Med (2016) 0.75
Sarcoidosis-associated fatigue: an often forgotten symptom--author reply. Expert Rev Clin Immunol (2013) 0.75
Response. Chest (2015) 0.75
Syndrome of pleural and retrosternal "bridging" fibrosis and retroperitoneal fibrosis in patients with asbestos exposure. BMJ Case Rep (2009) 0.75
The variability of sarcoidosis: can we predict it? Chest (2003) 0.75